STAT+: U.K. health officials and researchers try to carve a path for more individualized genetic treatments
LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies…
Category: government agencies
STAT+: Vertex hits speed bump in getting CRISPR sickle cell therapy covered in U.K.
LONDON — The U.K.’s cost-effectiveness watchdog said Thursday it is not yet recommending Vertex’s CRISPR-based…
Eli Lilly’s anti-vanity ad campaign for Oscars
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Banning WuXi is more complicated than it might sound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Beam is trading like it’s 2021
Want to stay on top of the science and politics driving biotech today? Sign up to get…
GSK pill works in uncomplicated gonorrhea
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novavax’s money is going in the wrong direction
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
Gilead sours on the ‘don’t eat me’ business
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Regeneron is interested in obesity treatments that combat muscle loss
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A scholar of the patient ‘revolution’ tracks the arc from powerlessness to influence
At the end of each chapter in “Rebel Health: A Field Guide to the Patient-Led…
23andMe breach targeted Chinese, Jewish populations
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Investigators fault Lilly plant for manufacturing issues
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The Senate health committee looks into its first subpoena in 40 years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The four biotech stories you need to read this morning
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novartis reportedly decides to pass on Cytokinetics
Want to stay on top of the science and politics driving biotech today? Sign up to get…
JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
Why CG Oncology will be the first test of 2024’s IPO waters
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Anavex’s slow journey to failure
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Morning Rounds: Our newsroom’s favorite stories of 2023
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Morning Rounds: Why health care costs are nearly a fifth of the GDP
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
BioMarin appeases an activist
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Morning Rounds: Americans’ health is trending downward, poll finds
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
FDA chastens pet companies over antibiotics
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Morning Rounds: Teen pregnancies down, but remain higher in the U.S.
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Tome Biosciences goes public today in another biotech megaround
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Morning Rounds: Preterm birth rates vary across the U.S., with the highest in the Southeast
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
STAT Health News: Abortion ‘companion networks,’ NEJM’s racist past, and other stories you need to read
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Morning Rounds: Couples share high blood pressure, and other health stories you should read today
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
STAT Morning Rounds: Six health news stories you need to start your day
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Johnson & Johnson bets heavy on AI-driven drug discovery
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Flagship Pioneering crosses the pond, opens a European front
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Medtronic isn’t afraid of Wegovy’s potential to disrupt
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Merck cough drug doesn’t pass panel scrutiny
Want to stay on top of the science and politics driving biotech today? Sign up to get…
How do we know Alzheimer’s drugs ‘work’?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The apparently strong correlation between biotech stocks and the price of eggs, explained
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Your morning biotech news roundup
Want to stay on top of the science and politics driving biotech today? Sign up to get…
‘Underwhelming’: NIH trials fail to test meaningful long Covid treatments — after 2.5 years and $1 billion
More than 2.5 years after the National Institutes of Health received a $1 billion mandate…
STAT+: HHS leader to vaccine makers: Set ‘reasonable’ prices for your next round of Covid-19 vaccines
Amid ongoing controversy over the cost of medicines, a key Biden administration official told Covid-19…
STAT+: U.S. seeks a new trial over royalties on Gilead HIV prevention pills
The U.S. government asked a federal judge to overturn a recent case in which a…
A 988 operator, faced with a flood of calls, turns to AI to boost counselor skills
Over 1,000 times a day, distressed people call crisis support lines operated by Protocall Services….
STAT+: USDA to push food producers to substantiate claims that animals are raised without antibiotics
The U.S. Department of Agriculture is launching a program to ensure food producers substantiate claims…
STAT+: FTC files lawsuit to block Amgen’s purchase of Horizon Therapeutics
The Federal Trade Commission on Tuesday sued to block Amgen’s $27.8 billion acquisition of Horizon…
STAT+: Scientific research will be threatened unless NIH overhauls systems for tracking non-human primates, report warns
A worsening shortage of non-human primates and an inadequate government response threatens to undermine biomedical…
STAT+: FDA report details problems at Global Pharma plant involved in eye drop recall
Global Pharma Healthcare, whose eye drops have been linked to dozens of serious reactions, failed…
STAT+: NIH rejects bid to cut a cancer drug’s price by sidestepping patents
In a long-awaited decision, the U.S. National Institutes of Health rejected a petition urging the…
STAT+: Controversial drug for premature birth is withdrawn by manufacturer after battle with FDA
After months of anticipation, the manufacturer of a controversial drug for premature births has agreed…
The FTC is finally ready take on health data leaks. The problem is bigger than GoodRx
The Federal Trade Commission took aim at prescription drug coupon site GoodRx this week in…
STAT+: FTC Commissioner criticizes $1.5 million GoodRx fine for health data leaks
On Wednesday, the Federal Trade Commission made history by enforcing, for the first time, its…